Literature DB >> 20615576

Local failure after complete resection of N0-1 non-small cell lung cancer.

Mert Saynak1, Nirmal K Veeramachaneni, Jessica L Hubbs, Jiho Nam, Bahjat F Qaqish, Janet E Bailey, Wonil Chung, Lawrence B Marks.   

Abstract

PURPOSE: To estimate the risk of local-regional failure (LRF) after surgery for operable NSCLC, and the effect of clinical/pathologic factors on this risk.
METHODS: Records of 335 patients undergoing complete resection (lobectomy, pneumonectomy) for pathological T1-4 N0-1 NSCLC (without post-operative radiation) from 1996 to 2006 were reviewed. Crude and actuarial estimated failure rates were computed; local-regional sites included ipsilateral lung, surgical stump, hilar, mediastinal, or supraclavicular nodes. Failure times in sub-groups were calculated with the Kaplan-Meier method and compared via log-rank test. Independent factors adversely affecting LRF were determined with Cox regression.
RESULTS: The median follow-up duration for event-free surviving patients was 40 months (range: 1-150). The crude and actuarial 5-year probability of any failure (LR or distant) were 33% and 43%, respectively. Of all failures; 37% were LR only, 35% LR and distant and 28% distant only. The 5-year crude and actuarial probability of LRF were 24% and 35% (95% CI: 29-42%). Five-year crude LRF rates for T1-2N0, T1-2N1, T3-4N0 and T3-4N1 disease were 19% (41/216), 27% (16/59), 37.5% (15/40) and 40% (8/20), respectively. The corresponding actuarial estimates were T1-2N0 28%, T1-2N1 39%, T3-4N0 50% and T3-4N1 67%. In Cox multiple regression analysis, lymphovascular space invasion (p=0.03, HR: 1.7) and tumor size (p=0.01, HR: 1.67 for 5 cm increment) were associated with an increased risk of LRF.
CONCLUSION: Five-year LRF rates are ≥19% in essentially all patient subsets. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20615576     DOI: 10.1016/j.lungcan.2010.06.001

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  14 in total

Review 1.  Local recurrence following lung cancer surgery: incidence, risk factors, and outcomes.

Authors:  David Fedor; W Rainey Johnson; Sunil Singhal
Journal:  Surg Oncol       Date:  2013-05-20       Impact factor: 3.279

2.  Visiting an old foe: distant recurrence following R0 lobectomy for pathological N0 lung adenocarcinoma.

Authors:  Sameer A Hirji; Thomas A D'Amico
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma.

Authors:  Jian Zhou; Francisco Sanchez-Vega; Raul Caso; Kay See Tan; Whitney S Brandt; Gregory D Jones; Shi Yan; Prasad S Adusumilli; Matthew Bott; James Huang; James M Isbell; Smita Sihag; Daniela Molena; Valerie W Rusch; Walid K Chatila; Natasha Rekhtman; Fan Yang; Marc Ladanyi; David B Solit; Michael F Berger; Nikolaus Schultz; David R Jones
Journal:  Clin Cancer Res       Date:  2019-08-27       Impact factor: 12.531

Review 4.  Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies.

Authors:  David A Mahvi; Rong Liu; Mark W Grinstaff; Yolonda L Colson; Chandrajit P Raut
Journal:  CA Cancer J Clin       Date:  2018-10-17       Impact factor: 508.702

5.  Lung cancer prognosis before and after recurrence in a population-based setting.

Authors:  Dario Consonni; Mariaelena Pierobon; Mitchell H Gail; Maurizia Rubagotti; Melissa Rotunno; Alisa Goldstein; Lynn Goldin; Jay Lubin; Sholom Wacholder; Neil E Caporaso; Pier Alberto Bertazzi; Margaret A Tucker; Angela C Pesatori; Maria Teresa Landi
Journal:  J Natl Cancer Inst       Date:  2015-03-23       Impact factor: 13.506

Review 6.  Evidence-based recommendations of postoperative radiotherapy in lung cancer from Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).

Authors:  A Gómez; J A González; F Couñago; C Vallejo; F Casas; N Rodríguez de Dios
Journal:  Clin Transl Oncol       Date:  2015-08-18       Impact factor: 3.405

7.  Relationship between EGFR gene mutation and local metastasis of resectable lung adenocarcinoma.

Authors:  Yunqiang Nie; Wei Gao; Na Li; Wenjun Chen; Hui Wang; Cuiyun Li; Haiyan Zhang; Ping Han; Yingmei Zhang; Xin Lv; Xinyi Xu; Hongyan Liu
Journal:  World J Surg Oncol       Date:  2017-03-03       Impact factor: 2.754

8.  Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy.

Authors:  Chengcheng Fan; Shugeng Gao; Zhouguang Hui; Jun Liang; Jima Lv; Xiaozhen Wang; Jie He; Luhua Wang
Journal:  Radiat Oncol       Date:  2013-12-09       Impact factor: 3.481

9.  [Radiofrequency ablation for lung neoplasms with isolated postsurgical local 
recurrences or metastases of non-small cell lung cancer].

Authors:  Baodong Liu; Lei Liu; Mu Hu; Kun Qian; Yuanbo Li; Xiuyi Zhi
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-06-20

10.  Salvage radiotherapy with simultaneous integrated boost in non small-cell lung cancer patients with mediastinal relapse after surgery: a pilot study.

Authors:  L Nicosia; L Agolli; C Reverberi; V De Sanctis; L Marinelli; G Minniti; J Di Muzio; M Valeriani; M F Osti
Journal:  Radiat Oncol       Date:  2018-10-23       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.